Description: Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Home Page: respiri.co
432 St Kilda Road
Melbourne,
VIC
3004
Australia
Phone:
61 3 9653 9160
Officers
| Name | Title |
|---|---|
| Mr. Nicholas Smedley | Executive Chairman |
| Mr. Marjan Mikel B.Sc., M.A.I.C.D. | CEO, MD & Executive Director |
| Mr. Peter Hildebrandt | Chief Operations Officer |
| Mr. George Vlachodimitropoulos | Chief Technology Officer |
| Dr. Samaneh Sarraf Shirazi | Chief Research Officer |
| Mr. Theo Antonopoulos | Chief Commercial Officer |
| Mr. William Sigsbee | Head of US Operations & Chief Commercial Officer for the US market |
| Mr. Justin Mouchacca B.Bus (Acc), C.A., CA | Joint Company Secretary |
| Ms. Nova Anne Taylor | Joint Company Secretary |
| Prof. Noam Gavriely | Medical & Scientific Advisor |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0.0759 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 45.7881 |
| Price-to-Sales TTM: | 12.7732 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |